Chemours (CC) Q3 Earnings Miss Estimates

Core Insights - Chemours reported quarterly earnings of $0.20 per share, missing the Zacks Consensus Estimate of $0.24 per share, and down from $0.40 per share a year ago, representing an earnings surprise of -16.67% [1] - The company posted revenues of $1.5 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.19%, with year-ago revenues also at $1.5 billion [2] - Chemours shares have declined approximately 28.7% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.21 on revenues of $1.4 billion, and for the current fiscal year, it is $1.15 on revenues of $5.87 billion [7] - The estimate revisions trend for Chemours was unfavorable prior to the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Chemical - Diversified industry, to which Chemours belongs, is currently ranked in the bottom 9% of over 250 Zacks industries, suggesting a challenging environment for the stock [8]